Clinical Snippets.

  • Published 2017 in Experimental dermatology


Because single efficacious treatment options are unavailable for systemic sclerosis (SSc), which is characterized by immune abnormalities, vasculopathy, and tissue fibrosis, assessment of preexisting antifibrotic drugs for their ability to control SSc is attractive. Yamashita and colleagues Brand and colleagues reported the potential of JP4-039, a… (More)
DOI: 10.1111/exd.13313